Fangxin Hong

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of medical Internet research

Clinical cancer research : an official journal of the American Association for Cancer Research

Dana Farber Cancer Institute

University of California Davis (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Aug 1o 2007

United States

Sr. Research scientist :: Biostatistics and Computational biology

Education History

University of California Davis

United States

PHD :: Statistics

Publications

Amy S Clark, Fangxin Hong, Richard S Finn, Angela M DeMichele, Edith P Mitchell, James A Zwiebel, Fernanda I Arnaldez, Robert J Gray, Xin Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Mehmet Sitki Copur, Samer S Kasbari, Ravneet Thind, Barbara A Conley, Carlos L Arteaga, Peter J O'Dwyer, Lyndsay N Harris, Helen X Chen, Keith T Flaherty
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kari B Wisinski, Yael Flamand, Melissa A Wilson, Jason John Luke, Hussein A Tawbi, Fangxin Hong, Edith P Mitchell, James A Zwiebel, Helen Chen, Robert J Gray, Shuli Li, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Robert J Behrens, Kathryn P Pennington, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Trametinib in Patients With NF1- , GNAQ- , or GNA11 -Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 7 (2023)
Sarah C Rutherford, Jun Yin, Levi D Pederson, Gabriela Perez Burbano, Betsy LaPlant, Mazyar Shadman, Hongli Li, Michael L LeBlanc, Vaishalee P Kenkre, Fangxin Hong, Kristie A Blum, Travis Dockter, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara A Rosenbaum, Chaitra Ujjani, Paul M Barr, Joseph M Unger, Bruce D Cheson, Nancy L Bartlett, Brad S Kahl, Jonathan W Friedberg, Sumithra J Mandrekar, John P Leonard
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Grzegorz S Nowakowski, Fangxin Hong, David W Scott, William R Macon, Rebecca L King, Thomas M Habermann, Nina Wagner-Johnston, Carla Casulo, James L Wade, Gauri G Nagargoje, C M Reynolds, Jonathon B Cohen, Nadia Khan, Jennifer Effie Amengual, Kristy L Richards, Richard F Little, John P Leonard, Jonathan W Friedberg, Lale Kostakoglu, Brad S Kahl, Thomas E Witzig
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Mizuki Nishino, Fangxin Hong, Biagio Ricciuti, Hiroto Hatabu, Mark M Awad
Tumor Response Dynamics During First-Line Pembrolizumab Therapy in Patients With Advanced Non-Small-Cell Lung Cancer. JCO precision oncology 5 (2021)
Rachel A Pozzar, Marilyn J Hammer, Meghan L Underhill, Alexi A Wright, James A Tulsky, Fangxin Hong, Daniel Alexander Gundersen, Donna L Berry
Threats of Bots and Other Bad Actors to Data Quality Following Research Participant Recruitment Through Social Media: Cross-Sectional Questionnaire. Journal of medical Internet research 22 (10) (2020)
Robert Knoerl, Fangxin Hong, Traci M Blonquist, Donna L Berry
Impact of Electronic Self-Assessment and Self-Care Technology on Adherence to Clinician Recommendations and Self-Management Activity for Cancer Treatment-Related Symptoms: Secondary Analysis of a Randomized Controlled Trial. JMIR cancer 5 (1) (2019)

Fangxin Hong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fangxin Hong